-
Posted: March 30th, 2015, 2:00am GMT
Conditions: Carcinoma In Situ; Central Nervous System Neoplasm; Childhood Immature Teratoma; Childhood Langerhans Cell Histiocytosis; Childhood Mature Teratoma; Congenital Mesoblastic Nephroma; Desmoid Fibromatosis; Ganglioneuroma; Lymphoproliferative Disorder; Malignant Solid Neoplasm; Melanocytic Neoplasm; Myeloproliferative Neoplasm; Neuroendocrine Neoplasm; Stromal Neoplasm
Interventions: Other: Cytology Specimen Collection Procedure; Other: Medical Chart Review
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting
-
Posted: March 20th, 2015, 2:00am GMT
Conditions: Leukemia, Acute Lymphoblastic
Interventions: Drug: Blinatumomab; Drug: Dexamethasone; Drug: Vincrisitne; Drug: Daunorubicin; Drug: Methotrexate; Drug: Ifosfamide; Drug: PEG-asparaginase; Drug: Erwinia-asparaginase
Sponsors: Amgen
Completed
-
Posted: March 20th, 2015, 2:00am GMT
Conditions: Breast Cancer
Interventions: Other: No intervention
Sponsors: Hoffmann-La Roche
Completed
-
Posted: March 18th, 2015, 2:00am GMT
Conditions: Metastatic Brain Tumor; Primary Brain Tumor; Epileptic/Seizure Foci; Movement Disorders
Interventions: Device: NeuroBlate System
Sponsors: Monteris Medical
Completed
-
Posted: March 17th, 2015, 2:00am GMT
Conditions: Advanced Malignant Solid Neoplasm; Recurrent Brain Neoplasm; Recurrent Malignant Solid Neoplasm; Refractory Brain Neoplasm
Interventions: Drug: Cyclophosphamide; Drug: Dasatinib; Other: Laboratory Biomarker Analysis; Drug: Temsirolimus
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Active, not recruiting
-
Posted: March 17th, 2015, 2:00am GMT
Conditions: Primary Brain Tumor
Interventions: Procedure: NeuroBlate® System Therapy
Sponsors: Monteris Medical
Completed
-
Posted: March 12th, 2015, 2:00am GMT
Conditions: Corneal Disease; Blepharitis; Lacrimal Apparatus Diseases
Interventions: Device: Handheld IVCM Vivascope 3000 (Caliber/Mavig) anesthesic eyedrop : oxybuprocaïne Thea 1,6 mg/0,4 ml; Device: Multifluorescence IVCM vivascope 1500 ML (Caliber/Mavig); Procedure: microangiography
Sponsors: Centre Hospitalier Universitaire de Saint Etienne
Completed
-
Posted: March 11th, 2015, 2:00am GMT
Conditions: Leukemia
Interventions: Drug: Alemtuzumab; Drug: Etoposide; Drug: Dexamethasone; Drug: Methotrexate; Behavioral: Phone Call; Drug: Tocilizumab
Sponsors: M.D. Anderson Cancer Center
Completed
-
Posted: March 3rd, 2015, 3:00am GMT
Conditions: Brain Cancer; Glioblastoma
Interventions: Behavioral: psychometric tests, questionnaires and neurocognitive assessments
Sponsors: Memorial Sloan Kettering Cancer Center; Weill Medical College of Cornell University
Active, not recruiting